Clinical Trials Browser

OTHER × Pathologic Complete Response × Afatinib × Clear all

NCT02511847 2016-04-15

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

Phase 2 Unknown

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms